Rifampicin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Rifampicin 是一种有效的广谱抗生素，可抵抗细菌病原体。Rifampicin 具有抗流感病毒活性。Rifampicin 具有抗正痘活性。

Rifampicin is a bactericidal antibiotic drug of the rifamycin group.(In Vitro):Rifampicin (100 mg/mL) can block the functional activity of P-glycoprotein. Rifampicin is not a substract for P-glycoprotein. The mechanism of rifampicin resistance is unassociated with the functional activity of P-glycoprotein.(In Vivo):Rifampicin (200, 400 mg/kg) can induce fatty liver at high concentration. Rifampicin (30 mg/kg, i.p.) treatment of S464P biofilms in vivo results in a slight decline, but earlier rebinds in bioluminescence from these catheters compared with the parental signal, whereas rifampicin has no affect on bioluminescence in mice infected with mutant H481Y.

Rifampicin (100 microg/mL) can block the functional activity of P-glycoprotein. Rifampicin is not a substract for P-glycoprotein. The mechanism of rifampicin resistance is unassociated with the functional activity of P-glycoprotein.

Rifampicin (200, 400 mg/kg) can induce fatty liver at high concentration. Rifampicin (30 mg/kg, i.p.) treatment of S464P biofilms in vivo results in a slight decline, but earlier rebinds in bioluminescence from these catheters compared with the parental signal, whereas rifampicin has no affect on bioluminescence in mice infected with mutant H481Y.

NIH 10782 | NSC 113926 | Rifampin

Microbiology/Virology

Antifection

14-α Demethylase| DNA/RNA Synthesis

Infection

——

13292-46-1

822.94

C43H58N4O12

>98% (HPLC)

DMSO: 100 mg/mL (121.51 mM)

CC(O[C@@H]([C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(C)\C(N1)=O)[C@H](C)[C@@H](OC)/C=C/O[C@](O2)(C)C(C3=C2C(C)=C(O)C4=C3C(O)=C(/C=N/N5CCN(C)CC5)C1=C4O)=O)=O

(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate

(-20℃)

With Ice Pack

≥ 2 years